Home
About
FAQ
History (2)
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.
Ranganathan A, Powell BL. Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia. Clin Lymphoma Myeloma Leuk. 2010 Oct; 10 Suppl 3:S135-8.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Humans
Leukemia, Promyelocytic, Acute
Recurrence
Risk Factors
Survival Analysis
Time Factors
Treatment Outcome
authors with profiles
Bayard L. Powell MD